UnitedHealth Group Incorporated (UNH) Next Earnings Date & Options-Implied ±6.7% Move

$410.91 +0.94% NYSE • Public Delayed / 60s Snapshot

UnitedHealth Group Incorporated (UNH) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $364.66B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw B- · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+19.2% Base Target

WHALE OPTIONS TUG-OF-WAR:27% Call Buyers ($874.0K)

73% PutsMax Pain: $400.00

NEXT EST. REPORT: Nov 9, 2026 (~8 DAYS)

Options-Implied Post-Earnings ±6.7% Bell Curve

±$27.53 Expected Swing

TRADER CROWD SENTIMENT POLL

Will UNH Beat & Rip or Miss Next Quarter?

Trailing EPS: $15.58 • YoY Revenue Growth: 6.5%

48% Bullish Beat52% Bearish Miss

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
Q2 2026	2026-08-10	$112.03B	$5.48B	$10.25B	88.1%
Q1 2026	2026-05-05	$111.72B	$6.28B	$8.15B	88.5%
Q4 2025	2026-03-02	$113.22B	$10.0M	$160.0M	88.8%
Q3 2025	2025-10-28	$113.16B	$2.35B	$5.05B	88.9%
Q2 2025	2026-08-10	$111.62B	$3.41B	$6.30B	88.3%
Q1 2025	2026-05-05	$109.58B	$6.29B	$4.56B	88.7%

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Guest Options & Prop-Trading Strategist

Whale Flow & Momentum Playbook: Trading UNH & AI Leaders Without Chasing Tops

✓Exact institutional whale strikes & implied earnings range on UNH this week
✓How active traders scale setups using funded prop-firm accounts instead of risking savings
✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

UNH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +10.36%⚡ TESTING RESISTANCE

2026-10-30O $419.0H $420.9L $404.3C $407.0VOL 20.32M

RES: $407.5SUP: $348.4SMA50: $390.2SMA200: $362.8

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UNH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UNH Butterfly Map → + Track UNH →

Share Count & Dilution Monitor (#25)

-1.94% YoY Shares

SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.

Reverse-DCF Expectations Hurdle (#30)

19.5%/yr Implied 5Y Growth

vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UNH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

LLY → UNH Confirmed Filing

FDA label expansions of GLP-1 drugs into cardiovascular risk reduction, obstructive sleep apnea, and kidney disease unlock Medicare Part D statutory coverage, elevating UnitedHealthcare specialty drug costs.

AI Analyst Theses, Washington Policy & Company Video 🏛️ COMMENT_RULEMAKING: CMS Contract Year Medicare Advantage Capitation Benchmark & Part D GLP-1 Coverage Rulemaking (Centers for Medicare & Medicaid Services (HHS — 42 CFR Parts 422 & 423))

🎬 No recent verified company-specific video clip queued for UNH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →